The DOI matches its Crossref record; 351 of the 351 references it cites were found in a registry or an index.
Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
Open accessAbstract
Despite the success of renin-angiotensin system (RAS) blockade by angiotensin-converting enzyme (ACE) inhibitors and angiotensin II type 1 receptor (AT 1 R) blockers, current therapies for hypertension and related cardiovascular diseases are still inadequate.Identification of additional components of the RAS and associated vasoactive pathways, as well as new structural and functional insights into established targets, have led to novel therapeutic approaches with the potential to provide improved cardiovascular protection and better blood pressure control and/or reduced adverse side effects.The simultaneous modulation of several neurohumoral mediators in key interconnected blood pressure-regulating pathways has been an attractive approach to improve treatment efficacy, and several novel approaches involve combination therapy or dualacting agents.In addition, increased understanding of the complexity of the RAS has led to novel approaches aimed at upregulating the ACE2/angiotensin-(1-7)/Mas axis to counter-regulate the harmful effects of the ACE/angiotensin II/angiotensin III/AT 1 R axis.These advances have opened new avenues for the development of novel drugs targeting the RAS to better treat hypertension and heart failure.Here we focus on new therapies in preclinical and early clinical stages of development, including novel small molecule inhibitors and receptor agonists/ antagonists, less conventional strategies such as gene therapy to suppress angiotensinogen at the RNA level, recombinant ACE2 protein, and novel bispecific designer peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Angiotensin-neprilysin inhibition versus enalapril in heart failure
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J. L., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409077 · Cited by 6,957
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
On the size of the active site in proteases. I. Papain
Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,204
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
Maisel, A. S., Krishnaswamy, P., Nowak, R. M., McCord, J., Hollander, J. E., Duc, P., Omland, T., Storrow, A. B., Abraham, W. T., Wu, A. H. B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020233 · Cited by 3,362
McMurray, J. J., Östergren, J., Swedberg, K., Granger, C. B., Held, P., Michelson, E. L., Olofsson, B., Yusuf, S., & Pfeffer, M. A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14283-3 · Cited by 2,604
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,031
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Pitt, B., Poole-Wilson, P. A., Segal, R., Martinez, F. A., Dickstein, K., Camm, A. J., Konstam, M. A., Riegger, G., Klinger, G. H., Neaton, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02213-3 · Cited by 1,961
Pharmacology of bradykinin and related kinins.
Regoli, D., & Barabé, J. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06836-x · Cited by 1,892
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Granger, C. B., McMurray, J. J., Yusuf, S., Held, P., Michelson, E. L., Olofsson, B., Östergren, J., Pfeffer, M. A., & Swedberg, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14284-5 · Cited by 1,686
Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology.
Rubanyi, G. M., & Polokoff, M. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06809-7 · Cited by 1,654
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., & Yasue, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115146 · Cited by 1,354
Angiotensin-neprilysin inhibition in acute decompensated heart failure
Velazquez, E. J., Morrow, D. A., DeVore, A. D., Duffy, C. I., Ambrosy, A. P., McCague, K., Rocha, R., & Braunwald, E. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812851 · Cited by 1,260
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor
Murphy, T. J., Alexander, R. W., Griendling, K. K., Runge, M. S., & Bernstein, K. E. (1991) · Nature · doi:10.1038/351233a0 · Cited by 1,252
Effect of Nesiritide in Patients with Acute Decompensated Heart Failure
O'Connor, C. M., Starling, R. C., Hernandez, A. F., Armstrong, P. W., Dickstein, K., Hasselblad, V., Heizer, G. M., Komajda, M., Massie, B. M., McMurray, J. J. V., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100171 · Cited by 1,252
Solomon, S. D., Zile, M., Pieske, B., Voors, A., Shah, A., Kraigher-Krainer, E., Shi, V., Bransford, T., Takeuchi, M., Gong, J., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61227-6 · Cited by 1,173
Oparil, S., Acelajado, M. C., Bakris, G. L., Berlowitz, D. R., Cífková, R., Dominiczak, A. F., Grassi, G., Jordan, J., Poulter, N. R., Rodgers, A., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.14 · Cited by 1,167
The ACE2/angiotensin-(1-7)/MAS Axis of the renin-angiotensin system: focus on angiotensin-(1-7)
Santos, R. A. S., Sampaio, W. O., Alzamora, A. C., Motta-Santos, D., Alenina, N., Bader, M., & Campagnole-Santos, M. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00023.2016 · Cited by 1,144
THE PREPARATION AND FUNCTION OF THE HYPERTENSIN-CONVERTING ENZYME
Skeggs, L. T., Kahn, J. R., & Shumway, N. P. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.3.295 · Cited by 1,032
Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
Ray, K. K., Landmesser, U., Leiter, L. A., Kallend, D., Dufour, R., Karakas, M., Hall, T., Troquay, R. P. T., Turner, T., Visseren, F. L. J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615758 · Cited by 992
Metabolic Regulation of Brain Aβ by Neprilysin
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, N. P., Gerard, C., Hama, E., Lee, H.-J., & Saido, T. C. (2001) · Science · doi:10.1126/science.1059946 · Cited by 961
Leeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 943
Xu, D., Emoto, N., Giaid, A., Slaughter, C., Kaw, S., deWit, D., & Yanagisawa, M. (1994) · Cell · doi:10.1016/0092-8674(94)90425-1 · Cited by 921
Colucci, W. S., Elkayam, U., Horton, D. P., Abraham, W. T., Bourge, R. C., Johnson, A. D., Wagoner, L. E., Givertz, M. M., Liang, C.-S., Neibaur, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430403 · Cited by 911
Israili, Z. H., & Hall, W. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-3-234 · Cited by 910 · cited 2×
“It was also thought that ACE inhibitor-associated angioedema is due to increased bradykinin (Israili and Hall, 1992; Fox et al., 1996) but recent clinical studies do not support this (Straka et al., 2017) .”
WRITING COMMITTEE MEMBERS, Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G., Fonarow, G. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000435 · Cited by 897
Cushman, D. W., Cheung, H. S., Sabo, E. F., & Ondetti, M. A. (1977) · Biochemistry · doi:10.1021/bi00644a014 · Cited by 892
Crystal structure of the human angiotensin-converting enzyme–lisinopril complex
Natesh, R., Schwager, S. L. U., Sturrock, E. D., & Acharya, K. R. (2003) · Nature · doi:10.1038/nature01370 · Cited by 888
Self-citationMechanisms regulating renin release
Davis, J. O., & Freeman, R. H. (1976) · Physiological Reviews · doi:10.1152/physrev.1976.56.1.1 · Cited by 874
Bordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., & Collins, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59701 · Cited by 872
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Sasaki, K., Yamano, Y., Bardhan, S., Iwai, N., Murray, J. J., Hasegawa, M., Matsudat, Y., & lnagami, T. (1991) · Nature · doi:10.1038/351230a0 · Cited by 811
Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology.
Roques, B. P., Noble, F., Daugé, V, Fournié-Zaluski, M. C., & Beaumont, A. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00449-1 · Cited by 756
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.
Soubrier, F., Alhenc-Gelas, F., Hubert, C., Allegrini, J., John, M., Tregear, G., & Corvol, P. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9386 · Cited by 750
Endothelin System: The Double-Edged Sword in Health and Disease
Kedzierski, R. M., & Yanagisawa, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.851 · Cited by 745
Functions of Angiotensin in the Central Nervous System
Phillips, I. M. (1987) · Annual Review of Physiology · doi:10.1146/annurev.ph.49.030187.002213 · Cited by 742
The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition
Atlas, S. A. (2007) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2007.13.s8-b.9 · Cited by 722
Kambayashi, Y., Bardhan, S., Takahashi, K., Tsuzuki, S., Inui, H., Hamakubo, T., & Inagami, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74499-8 · Cited by 714
The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice
Roques, B. P., Fournié-Zaluski, M. C., Soroca, E., Lecomte, J. M., Malfroy, B., Llorens, C., & Schwartz, J.-C. (1980) · Nature · doi:10.1038/288286a0 · Cited by 705
Angiotensin II type 2 receptor mediates programmed cell death.
Yamada, T., Horiuchi, M., & Dzau, V. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.156 · Cited by 697
Towler, P., Staker, B., Prasad, S. G., Menon, S., Tang, J., Parsons, T., Ryan, D., Fisher, M., Williams, D., Dales, N. A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311191200 · Cited by 696
Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., Hooper, N. M., & Turner, A. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505111200 · Cited by 694
High-affinity enkephalin-degrading peptidase in brain is increased after morphine
MALFROY, B., SWERTS, J. P., GUYON, A., ROQUES, B. P., & SCHWARTZ, J. C. (1978) · Nature · doi:10.1038/276523a0 · Cited by 642
Packer, M., Califf, R. M., Konstam, M. A., Krum, H., McMurray, J. J., Rouleau, J.-L., & Swedberg, K. (2002) · Circulation · doi:10.1161/01.cir.0000029801.86489.50 · Cited by 621
RICE, G. I., THOMAS, D. A., GRANT, P. J., TURNER, A. J., & HOOPER, N. M. (2004) · Biochemical Journal · doi:10.1042/bj20040634 · Cited by 619
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G., Fonarow, G. C., Givertz, M. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.011 · Cited by 613
Ruilope, L. M., Dukat, A., Böhm, M., Lacourcière, Y., Gong, J., & Lefkowitz, M. P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61966-8 · Cited by 599
Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart Failure
Raine, A. E. G., Erne, P., Bürgisser, E., Müller, F. B., Bolli, P., Burkart, F., & Bühler, F. R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150901 · Cited by 585
Kostis, J. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.014 · Cited by 579
Sampaio, W. O., Souza dos Santos, R. A., Faria-Silva, R., da Mata Machado, L. T., Schiffrin, E. L., & Touyz, R. M. (2007) · Hypertension · doi:10.1161/01.hyp.0000251865.35728.2f · Cited by 562
Self-citationNeutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones 1
Erdös, E. G., & Skidgel, R. A. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.2.2521610 · Cited by 554
Yanagisawa, M., Inoue, A., Ishikawa, T., Kasuya, Y., Kimura, S., Kumagaye, S., Nakajima, K., Watanabe, T. X., Sakakibara, S., & Goto, K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6964 · Cited by 546
(2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432019 · Cited by 526
Santos, R. A. S., Ferreira, A. J., Verano-Braga, T., & Bader, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0341 · Cited by 523
(2017) · Circulation · doi:10.1161/cir.0000000000000491 · Cited by 510
Gu, J., Noe, A., Chandra, P., Al‐Fayoumi, S., Ligueros‐Saylan, M., Sarangapani, R., Maahs, S., Ksander, G., Rigel, D. F., Jeng, A. Y., et al. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009343932 · Cited by 505
AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration
AbdAlla, S., Lother, H., & Quitterer, U. (2000) · Nature · doi:10.1038/35024095 · Cited by 503
Edwards, B. S., Zimmerman, R. S., Schwab, T. R., Heublein, D. M., & Burnett, J. C. (1988) · Circulation Research · doi:10.1161/01.res.62.2.191 · Cited by 484
Self-citationYoung, D., Waitches, G., Birchmeier, C., Fasano, O., & Wigler, M. (1986) · Cell · doi:10.1016/0092-8674(86)90785-3 · Cited by 481
Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat.
Campbell, D. J., & Habener, J. F. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112566 · Cited by 479
Silencing disease genes in the laboratory and the clinic
Watts, J. K., & Corey, D. R. (2012) · The Journal of Pathology · doi:10.1002/path.2993 · Cited by 470
The Angiotensin II AT2 Receptor Is an AT1Receptor Antagonist
AbdAlla, S., Lother, H., Abdel-tawab, A. M., & Quitterer, U. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105253200 · Cited by 463
The purification and specificity of a neutral endopeptidase from rabbit kidney brush border
Kerr, M. A., & Kenny, A. J. (1974) · Biochemical Journal · doi:10.1042/bj1370477 · Cited by 460
Natriuretic peptide system in human heart failure.
Wei, C. M., Heublein, D. M., Perrella, M. A., Lerman, A., Rodeheffer, R. J., McGregor, C. G., Edwards, W. D., Schaff, H. V., & Burnett, J. C. (1993) · Circulation · doi:10.1161/01.cir.88.3.1004 · Cited by 460
Self-citationHydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase
Skidgel, R. A., Engelbrecht, S., Johnson, A. R., & Erdös, E. G. (1984) · Peptides · doi:10.1016/0196-9781(84)90020-2 · Cited by 458
McMurray, J. J. V., Packer, M., Desai, A. S., Gong, J., Lefkowitz, M. P., Rizkala, A. R., Rouleau, J., Shi, V. C., Solomon, S. D., Swedberg, K., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft052 · Cited by 457
Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
Damman, K., Gori, M., Claggett, B., Jhund, P. S., Senni, M., Lefkowitz, M. P., Prescott, M. F., Shi, V. C., Rouleau, J. L., Swedberg, K., et al. (2018) · JACC: Heart Failure · doi:10.1016/j.jchf.2018.02.004 · Cited by 456
First-line drugs for hypertension
Wright, J. M., Musini, V. M., & Gill, R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001841.pub3 · Cited by 452
Effects of Estrogen Replacement Therapy on the Renin-Angiotensin System in Postmenopausal Women
Schunkert, H., Danser, A. H. J., Hense, H.-W., Derkx, F. H. M., Ku¨rzinger, S., & Riegger, G. A. J. (1997) · Circulation · doi:10.1161/01.cir.95.1.39 · Cited by 438
Self-citationDiscovery and Characterization of Alamandine: A Novel Component of the Renin–Angiotensin System
Lautner, R. Q., Villela, D. C., Fraga-Silva, R. A., Silva, N., Verano-Braga, T., Costa-Fraga, F., Jankowski, J., Jankowski, V., Sousa, F., Alzamora, A., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301077 · Cited by 438
Page, I. H., & Helmer, O. M. (1940) · Journal of Experimental Medicine · doi:10.1084/jem.71.1.29 · Cited by 434
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
Jiang, F., Yang, J., Zhang, Y., Dong, M., Wang, S., Zhang, Q., Liu, F. F., Zhang, K., & Zhang, C. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.59 · Cited by 426
G-Protein–Coupled Receptor Mas Is a Physiological Antagonist of the Angiotensin II Type 1 Receptor
Kostenis, E., Milligan, G., Christopoulos, A., Sanchez-Ferrer, C. F., Heringer-Walther, S., Sexton, P. M., Gembardt, F., Kellett, E., Martini, L., Vanderheyden, P., et al. (2005) · Circulation · doi:10.1161/01.cir.0000160867.23556.7d · Cited by 415
Lenkei, Z., Palkovits, M., Corvol, P., & Llorens-Cortès, C. (1997) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1997.0155 · Cited by 406
Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX
Turner, A. J., & Tanzawa, K. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.5.9141502 · Cited by 402
Itoh, Y., Yanagisawa, M., Ohkubo, S., Kimura, C., Kosaka, T., Inoue, A., Ishida, N., Mitsui, Y., Onda, H., Fujino, M., et al. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80867-6 · Cited by 399
The mas oncogene encodes an angiotensin receptor
Jackson, T. R., Blair, L. A. C., Marshall, J., Goedert, M., & Hanley, M. R. (1988) · Nature · doi:10.1038/335437a0 · Cited by 395
Structure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography
Zhang, H., Unal, H., Gati, C., Han, G. W., Liu, W., Zatsepin, N. A., James, D., Wang, D., Nelson, G., Weierstall, U., et al. (2015) · Cell · doi:10.1016/j.cell.2015.04.011 · Cited by 382
Haschke, M., Schuster, M., Poglitsch, M., Loibner, H., Salzberg, M., Bruggisser, M., Penninger, J., & Krähenbühl, S. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0072-7 · Cited by 361
Self-citationInduction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells.
Imai, T., Hirata, Y., Emori, T., Yanagisawa, M., Masaki, T., & Marumo, F. (1992) · Hypertension · doi:10.1161/01.hyp.19.6.753 · Cited by 359
Natriuretic peptide metabolism, clearance and degradation
Potter, L. R. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2011.08082.x · Cited by 357
Molecular Physiology of Membrane Guanylyl Cyclase Receptors
Kuhn, M. (2016) · Physiological Reviews · doi:10.1152/physrev.00022.2015 · Cited by 356
Namkung, Y., Le Gouill, C., Lukashova, V., Kobayashi, H., Hogue, M., Khoury, E., Song, M., Bouvier, M., & Laporte, S. A. (2016) · Nature Communications · doi:10.1038/ncomms12178 · Cited by 347
The renin-angiotensin system: going beyond the classical paradigms
Santos, R. A. S., Oudit, G. Y., Verano-Braga, T., Canta, G., Steckelings, U. M., & Bader, M. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00723.2018 · Cited by 340
Bernstein, K. E., Ong, F. S., Blackwell, W.-L. B., Shah, K. H., Giani, J. F., Gonzalez-Villalobos, R. A., Shen, X. Z., & Fuchs, S. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006809 · Cited by 324
Angiotensin Synthesis in the Brain and Increased Turnover in Hypertensive Rats
Ganten, D., Hermann, K., Bayer, C., Unger, T., & Lang, R. E. (1983) · Science · doi:10.1126/science.6879184 · Cited by 323
Zini, S., Fournie-Zaluski, M. C., Chauvel, E., Roques, B. P., Corvol, P., & Llorens-Cortes, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11968 · Cited by 322
Self-citationAngiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
Tallant, E. A., Ferrario, C. M., & Gallagher, P. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00941.2004 · Cited by 318
Shirotani, K., Tsubuki, S., Iwata, N., Takaki, Y., Harigaya, W., Maruyama, K., Kiryu-Seo, S., Kiyama, H., Iwata, H., Tomita, T., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008511200 · Cited by 311
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction
Solomon, S. D., Rizkala, A. R., Gong, J., Wang, W., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., et al. (2017) · JACC: Heart Failure · doi:10.1016/j.jchf.2017.04.013 · Cited by 310
Mapping of angiotensin II receptor subtype heterogeneity in rat brain
Song, K., Allen, A. M., Paxinos, G., & Mendelsohn, F. A. O. (1992) · Journal of Comparative Neurology · doi:10.1002/cne.903160407 · Cited by 303
Karnik, S. S., Unal, H., Kemp, J. R., Tirupula, K. C., Eguchi, S., Vanderheyden, P. M. L., & Thomas, W. G. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.010454 · Cited by 302
Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation.
Thunnissen, M. M. G. M., Nordlund, P., & Haeggström, J. Z. (2001) · Nature Structural Biology · doi:10.1038/84117 · Cited by 300
Bradykinin–evoked sensitization of airway sensory nerves: A mechanism for ACE–inhibitor cough
Fox, A. J., Lalloo, U. G., Belvisi, M. G., Bernareggi, M., Chung, K. F., & Barnes, P. J. (1996) · Nature Medicine · doi:10.1038/nm0796-814 · Cited by 291
Metabolism of Angiotensin-(1–7) by Angiotensin-Converting Enzyme
Chappell, M. C., Pirro, N. T., Sykes, A., & Ferrario, C. M. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.362 · Cited by 289
Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors
Bosnyak, S., Jones, E. S., Christopoulos, A., Aguilar, M.-I., Thomas, W. G., & Widdop, R. E. (2011) · Clinical Science · doi:10.1042/cs20110036 · Cited by 288
Treating Disease at the RNA Level with Oligonucleotides
Levin, A. A. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1705346 · Cited by 287
Santos, R. A. S., Campagnole-Santos, M. J., Baracho, N. C. V., Fontes, M. A. P., Silva, L. C. S., Neves, L. A. A., R. Oliveira, D., Caligiorne, S. M., Rodrigues, A. R. V., Gropen, C., et al. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90104-x · Cited by 286
Oefner, C., D’Arcy, A., Hennig, M., Winkler, F. K., & Dale, G. E. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3492 · Cited by 280
New approaches in the treatment of hypertension
Oparil, S., & Schmieder, R. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.303603 · Cited by 276
Cloning and expression of a novel angiotensin II receptor subtype.
Sandberg, K., Ji, H., Clark, A. J., Shapira, H., & Catt, K. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50109-0 · Cited by 274
Hernández Prada, J. A., Ferreira, A. J., Katovich, M. J., Shenoy, V., Qi, Y., Santos, R. A. S., Castellano, R. K., Lampkins, A. J., Gubala, V., Ostrov, D. A., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108944 · Cited by 271
Hawkridge, A. M., Heublein, D. M., Bergen, H. R., Cataliotti, A., Burnett, J. C., & Muddiman, D. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508782102 · Cited by 266
Self-citationLiver Angiotensinogen Is the Primary Source of Renal Angiotensin II
Matsusaka, T., Niimura, F., Shimizu, A., Pastan, I., Saito, A., Kobori, H., Nishiyama, A., & Ichikawa, I. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011121159 · Cited by 261
Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000207 · Cited by 259
Wei, L., Clauser, E., Alhenc-Gelas, F., & Corvol, P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42224-7 · Cited by 256
Welches, W. R., Bridget Brosnihan, K., & Ferrario, C. M. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90108-f · Cited by 254
A Randomized Trial of Icatibant in ACE-Inhibitor–Induced Angioedema
Baş, M., Greve, J., Stelter, K., Havel, M., Strassen, U., Rotter, N., Veit, J., Schossow, B., Hapfelmeier, A., Kehl, V., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1312524 · Cited by 253
Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
Epelman, S., Tang, W. H. W., Chen, S. Y., Van Lente, F., Francis, G. S., & Sen, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.088 · Cited by 250
Brain renin–angiotensin system dysfunction in hypertension: recent advances and perspectives
Veerasingham, S. J., & Raizada, M. K. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705262 · Cited by 250
The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase).
Vijayaraghavan, J., Scicli, A. G., Carretero, O. A., Slaughter, C., Moomaw, C., & Hersh, L. B. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77280-3 · Cited by 245
Important roles for angiotensin III and IV in the brain renin-angiotensin system
Wright, J. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00019-2 · Cited by 244
Deddish, P. A., Marcic, B., Jackman, H. L., Wang, H.-Z., Skidgel, R. A., & Erdös, E. G. (1998) · Hypertension · doi:10.1161/01.hyp.31.4.912 · Cited by 244
Haynes, R., Judge, P. K., Staplin, N., Herrington, W. G., Storey, B. C., Bethel, A., Bowman, L., Brunskill, N., Cockwell, P., Hill, M., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034818 · Cited by 243
Essential role for collectrin in renal amino acid transport
Danilczyk, U., Sarao, R., Remy, C., Benabbas, C., Stange, G., Richter, A., Arya, S., Pospisilik, J. A., Singer, D., Camargo, S. M. R., et al. (2006) · Nature · doi:10.1038/nature05475 · Cited by 242
Regulation and Intracellular Trafficking Pathways of the Endothelin Receptors
Bremnes, T., Paasche, J. D., Mehlum, A., Sandberg, C., Bremnes, B., & Attramadal, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000142200 · Cited by 242
Khan, B. A., Perkins, A. J., Gao, S., Hui, S. L., Campbell, N. L., Farber, M. O., Chlan, L. L., & Boustani, M. A. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002368 · Cited by 231
Vascular gp91 phox : Beyond the Endothelium
Pagano, P. J. (2000) · Circulation Research · doi:10.1161/01.res.87.1.1 · Cited by 229
Biology of natriuretic peptides and their receptors
Pandey, K. N. (2005) · Peptides · doi:10.1016/j.peptides.2004.09.024 · Cited by 223
A protein complex in the brush‐border membrane explains a Hartnup disorder allele
Kowalczuk, S., Bröer, A., Tietze, N., Vanslambrouck, J. M., Rasko, J. E. J., & Bröer, S. (2008) · The FASEB Journal · doi:10.1096/fj.08-107300 · Cited by 220
Structural basis for selectivity and diversity in angiotensin II receptors
Zhang, H., Han, G. W., Batyuk, A., Ishchenko, A., White, K. L., Patel, N., Sadybekov, A., Zamlynny, B., Rudd, M. T., Hollenstein, K., et al. (2017) · Nature · doi:10.1038/nature22035 · Cited by 220
Biochemical Properties of the Ovarian Granulosa Cell Type 2-Angiotensin II Receptor*
PUCELL, A. G., HODGES, J. C., SEN, I., BUMPUS, F. M., & HUSAIN, A. (1991) · Endocrinology · doi:10.1210/endo-128-4-1947 · Cited by 215
Gyurko, R., Wielbo, D., & Ian Phillips, M. (1993) · Regulatory Peptides · doi:10.1016/0167-0115(93)90438-e · Cited by 211
Walters, P. E., Gaspari, T. A., & Widdop, R. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000160325.59323.b8 · Cited by 206
Epelman, S., Shrestha, K., Troughton, R. W., Francis, G. S., Sen, S., Klein, A. L., & Wilson Tang, W. H. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.014 · Cited by 200
AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium
Wiemer, G., Dobrucki, L. W., Louka, F. R., Malinski, T., & Heitsch, H. (2002) · Hypertension · doi:10.1161/01.hyp.0000037979.53963.8f · Cited by 199
Angiotensin II(3–8) (ANG IV) hippocampal binding: Potential role in the facilitation of memory
Wright, J. W., Miller-Wing, A. V., Shaffer, M. J., Higginson, C., Wright, D. E., Hanesworth, J. M., & Harding, J. W. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90297-o · Cited by 198
Barton, M., Shaw, S., d'uscio, L. V., Moreau, P., & Lüscher, T. F. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7394 · Cited by 198
Robl, J. A., Sun, C.-Q., Stevenson, J., Ryono, D. E., Simpkins, L. M., Cimarusti, M. P., Dejneka, T., Slusarchyk, W. A., Chao, S., Stratton, L., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970041e · Cited by 198
Aminopeptidase A inhibitors as potential central antihypertensive agents
Reaux, A., Fournie-Zaluski, M. C., David, C., Zini, S., Roques, B. P., Corvol, P., & Llorens-Cortes, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13415 · Cited by 197
Self-citationRoles of Angiotensin Peptides and Recombinant Human ACE2 in Heart Failure
Basu, R., Poglitsch, M., Yogasundaram, H., Thomas, J., Rowe, B. H., & Oudit, G. Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.064 · Cited by 196
Self-citationMori, J., Patel, V. B., Abo Alrob, O., Basu, R., Altamimi, T., DesAulniers, J., Wagg, C. S., Kassiri, Z., Lopaschuk, G. D., & Oudit, G. Y. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000672 · Cited by 192
Rice, G. I., Jones, A. L., Grant, P. J., Carter, A. M., Turner, A. J., & Hooper, N. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000244543.91937.79 · Cited by 190
Kimura, S., Kasuya, Y., Sawamura, T., Shinmi, O., Sugita, Y., Yanagisawa, M., Goto, K., & Masaki, T. (1989) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198900135-00003 · Cited by 183
Millan, M. A., Jacobowitz, D. M., Aguilera, G., & Catt, K. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11440 · Cited by 182
Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure
Vardeny, O., Miller, R., & Solomon, S. D. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2014.09.001 · Cited by 181
Endothelin receptor antagonists
Motte, S., McEntee, K., & Naeije, R. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.08.012 · Cited by 181
Interactions between endothelin-1 and the renin–angiotensin–aldosterone system
Rossi, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00110-8 · Cited by 180
Mas and Its Related G Protein–Coupled Receptors, Mrgprs
Bader, M., Alenina, N., Andrade-Navarro, M. A., & Santos, R. A. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008136 · Cited by 179
Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Hypertension · doi:10.1161/hyp.0000000000000018 · Cited by 176
Inhibition of Neutral Endopeptidase Causes Vasoconstriction of Human Resistance Vessels In Vivo
Ferro, C. J., Spratt, J. C., Haynes, W. G., & Webb, D. J. (1998) · Circulation · doi:10.1161/01.cir.97.23.2323 · Cited by 175
Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney
Pinheiro, S. V. B., Simões e Silva, A. C., Sampaio, W. O., de Paula, R. D., Mendes, E. P., Bontempo, E. D., Pesquero, J. B., Walther, T., Alenina, N., Bader, M., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000141438.64887.42 · Cited by 175
Masuyer, G., Schwager, S. L. U., Sturrock, E. D., Isaac, R. E., & Acharya, K. R. (2012) · Scientific Reports · doi:10.1038/srep00717 · Cited by 168
Self-citationDanser, A. H. J., van Kesteren, C. A. M., Bax, W. A., Tavenier, M., Derkx, F. H. M., Saxena, P. R., & Schalekamp, M. A. D. H. (1997) · Circulation · doi:10.1161/01.cir.96.1.220 · Cited by 167
Self-citationA Mammalian Peptidase specific for the Hydrolysis of N-Terminal α-L-Glutamyl and Aspartyl Residues
GLENNER, G. G., McMILLAN, P. J., & FOLK, J. E. (1962) · Nature · doi:10.1038/194867a0 · Cited by 166
de Lannoy, L. M., Danser, A. H. J., van Kats, J. P., Schoemaker, R. G., Saxena, P. R., & Schalekamp, M. A. D. H. (1997) · Hypertension · doi:10.1161/01.hyp.29.6.1240 · Cited by 164
Self-citationPacker, M., Claggett, B., Lefkowitz, M. P., McMurray, J. J. V., Rouleau, J. L., Solomon, S. D., & Zile, M. R. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30100-1 · Cited by 160
Georgiadis, D., Beau, F., Czarny, B., Cotton, J., Yiotakis, A., & Dive, V. (2003) · Circulation Research · doi:10.1161/01.res.0000081593.33848.fc · Cited by 157
Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions
Wright, J. W., & Harding, J. W. (1995) · Regulatory Peptides · doi:10.1016/0167-0115(95)00084-o · Cited by 156
Effects of Omapatrilat in Low, Normal, and High Renin Experimental Hypertension
Trippodo, N. C. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00404-4 · Cited by 156
Davisson, R. L., Yang, G., Beltz, T. G., Cassell, M. D., Johnson, A. K., & Sigmund, C. D. (1998) · Circulation Research · doi:10.1161/01.res.83.10.1047 · Cited by 156
Purification and characterization of endothelin-converting enzyme from rat lung.
Takahashi, M., Matsushita, Y., Iijima, Y., & Tanzawa, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36936-4 · Cited by 153
Long-term neprilysin inhibition — implications for ARNIs
Campbell, D. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.200 · Cited by 152
ACE Inhibitor-Induced Angioedema: a Review
Kostis, W. J., Shetty, M., Chowdhury, Y. S., & Kostis, J. B. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0859-x · Cited by 152
Abassi, Z. A., Karram, T., Ellaham, S., Winaver, J. M., & Hoffman, A. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.04.004 · Cited by 151
Kang, J., Posner, P., & Sumners, C. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.5.c1389 · Cited by 151
The Antithrombotic Effect of Angiotensin-(1-7) Involves Mas-Mediated NO Release from Platelets
Fraga-Silva, R. A., Pinheiro, S. V. B., Gonçalves, A. C. D. C., Alenina, N. V., Bäder, M., & Santos, R. A. S. (2008) · Molecular Medicine · doi:10.2119/2007-00073.fraga-silva · Cited by 146
Hata, N., Seino, Y., Tsutamoto, T., Hiramitsu, S., Kaneko, N., Yoshikawa, T., Yokoyama, H., Tanaka, K., Mizuno, K., Nejima, J., et al. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0130 · Cited by 144
Fuchs, S., Xiao, H., Hübert, C., Michaud, A., Campbell, D. J., Adams, J. W., Capecchi, M. R., Corvol, P. L., & Bernstein, K. E. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.097865 · Cited by 144
Shenoy, V., Kwon, K., Rathinasabapathy, A., Lin, S., Jin, G., Song, C., Shil, P. K., Nair, A. R., Qi, Y., Li, Q., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03871 · Cited by 143
Wei, A., Gu, Z., Li, J., Liu, X., Wu, X., Han, Y., & Pu, J. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003896 · Cited by 138
Treatment of Hypertension in Patients With Coronary Artery Disease
Rosendorff, C., Lackland, D. T., Allison, M., Aronow, W. S., Black, H. R., Blumenthal, R. S., Cannon, C. P., de Lemos, J. A., Elliott, W. J., Findeiss, L., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.02.038 · Cited by 138
Molinaro, G., Cugno, M., Perez, M., Lepage, Y., Gervais, N., Agostoni, A., & Adam, A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.038067 · Cited by 137
Fournié‐Zaluski, M., Fassot, C., Valentin, B., Djordjijević, D., Goazigo, A. R.-L., Corvol, P. L., Roques, B. P., & Llorens‐Cortés, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402312101 · Cited by 134
Tetzner, A., Gebolys, K., Meinert, C., Klein, S., Uhlich, A., Trebicka, J., Villacañas, Ó., & Walther, T. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07572 · Cited by 134
Uijl, E., Colafella, K. M. M., Sun, Y., Ren, L., van Veghel, R., Garrelds, I. M., VRIES, R. D., Poglitsch, M., Zlatev, I., Kim, J. B., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12703 · Cited by 134
Self-citationKang, J., Richards, E. M., Posner, P., & Sumners, C. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.1.c278 · Cited by 133
Packer, M., McMurray, J. J. V., Krum, H., Kiowski, W., Massie, B. M., Caspi, A., Pratt, C. M., Petrie, M. C., DeMets, D. L., Kobrin, I., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.02.021 · Cited by 132
Fryer, R. M., Segreti, J., Banfor, P. N., Widomski, D. L., Backes, B. J., Lin, C. W., Ballaron, S. J., Cox, B. F., Trevillyan, J. M., Reinhart, G. A., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707641 · Cited by 130 · cited 4×
“Fryer et al. (2008) showed that bradykinin is degraded in rats with an enzyme rank efficacy of ACE .”
InfluentialSavergnini, S. Q., Beiman, M., Lautner, R. Q., de Paula, V., Allahdadi, K. J., Pessoa, D. C., Costa-Fraga, F. P., Fraga-Silva, R. A., Cojocaru, G., Cohen, Y., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.152942 · Cited by 130
Secretory pathways in endothelin synthesis
Russell, F. D., & Davenport, A. P. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702315 · Cited by 128
Angiotensin-(1–7): Pharmacological properties and pharmacotherapeutic perspectives
Iusuf, D., Henning, R. H., van Gilst, W. H., & Roks, A. J. M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.090 · Cited by 127
Suwa, M., Seino, Y., Nomachi, Y., Matsuki, S., & Funahashi, K. (2005) · Circulation Journal · doi:10.1253/circj.69.283 · Cited by 126
Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease
Ferrario, C. M., & Mullick, A. E. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.020 · Cited by 126
Nagatsu, I., Nagatsu, T., Yamamoto, T., Glenner, G. G., & Mehl, J. W. (1970) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(70)90058-6 · Cited by 124
The past, present and future of renin–angiotensin aldosterone system inhibition
Mentz, R. J., Bakris, G. L., Waeber, B., McMurray, J. J. V., Gheorghiade, M., Ruilope, L. M., Maggioni, A. P., Swedberg, K. B., Piña, I. L., Fiuzat, M., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.007 · Cited by 121
Langenickel, T., Tsubouchi, C., Ayalasomayajula, S. P., Pal, P., Valentin, M., Hinder, M., Jhee, S. S., Gevorkyan, H., & Rajman, I. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12861 · Cited by 117
Cannon, J. A., Shen, L., Jhund, P. S., Kristensen, S. L., Køber, L., Chen, F., Gong, J., Lefkowitz, M. P., Rouleau, J. L., Shi, V. C., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.687 · Cited by 117
AT2 Receptor and Tissue Injury: Therapeutic Implications
Namsolleck, P., Recarti, C., Foulquier, S., Steckelings, U. M., & Unger, T. (2014) · Current Hypertension Reports · doi:10.1007/s11906-013-0416-6 · Cited by 115
Benzing, T. R., Fleming, I., Blaukat, A., Müller‐Esterl, W., & Busse, R. (1999) · Circulation · doi:10.1161/01.cir.99.15.2034 · Cited by 114
Angiotensin‐(1‐7): Pharmacology and New Perspectives in Cardiovascular Treatments
Trask, A. J., & Ferrario, C. M. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00012.x · Cited by 112
Galandrin, S., Denis, C., Boularan, C., Marie, J., M’Kadmi, C., Pilette, C., Dubroca, C., Nicaise, Y., Séguélas, M., N’Guyen, D., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.08118 · Cited by 112
Practical guidance on the use of sacubitril/valsartan for heart failure
Sauer, A. J., Cole, R. T., Jensen, B. C., Pal, J. D., Sharma, N. C., Yehya, A., & Vader, J. M. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9757-1 · Cited by 112
Klotz, S., Burkhoff, D., Garrelds, I. M., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehp012 · Cited by 111
Kininogens: More than cysteine protease inhibitors and kinin precursors
Lalmanach, G., Naudin, C., Lecaille, F., & Fritz, H. (2010) · Biochimie · doi:10.1016/j.biochi.2010.03.011 · Cited by 110
Enhancement of Bradykinin and Resensitization of Its B2Receptor
Marcic, B. M., Deddish, P. A., Jackman, H. L., & Erdös, E. G. (1999) · Hypertension · doi:10.1161/01.hyp.33.3.835 · Cited by 110
Cited by
Diretrizes Brasileiras de Hipertensão Arterial – 2020
Barroso, W. K. S., Rodrigues, C. I. S., Bortolotto, L. A., Mota-Gomes, M. A., Brandão, A. A., Feitosa, A. D. D. M., Machado, C. A., Poli-de-Figueiredo, C. E., Amodeo, C., Mion, D., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20201238 · Cited by 1,068
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Apicella, M., Campopiano, M. C., Mantuano, M., Mazoni, L., Coppelli, A., & Del Prato, S. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30238-2 · Cited by 903
Biomarkers associated with COVID-19 disease progression
Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A., & Ozben, T. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1770685 · Cited by 890
Danser, A. H. J., Epstein, M., & Batlle, D. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15082 · Cited by 457
Self-citationHess, D. C., Eldahshan, W., & Rutkowski, E. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00818-9 · Cited by 381
Metadata
- Authors
- Arendse, L. B., Danser, A. H. J., Poglitsch, M., Touyz, R. M., Burnett, J. C., Llorens-Cortes, C., Ehlers, M. R., & Sturrock, E. D.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 71
- Issue
- 4
- Pages
- 539-570
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2968716215
- Cited by
- 339
- References
- 351
- FWCI
- 35.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.